Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Cuenca

6 clinical trials in Cuenca, Spain. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Cuenca at a glance
6
clinical trials
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

6 trials in Cuenca

Open in trial search
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Dactylis Glomerata Pollen Extract
  • Sponsor:LETI Pharma S.L.U.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone Sodium Phosphate
  • Sponsor:Consorcio Centro De Investigacion Biomedica En Red
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Allergen Extract From Dactylis Glomerata Pollen, Glutaraldehyde-Modified
  • Sponsor:Inmunotek S.L.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Fundacion Grupo Espanol De Investigacion En Cancer De Mama
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years
  • Substances:Phleum Pratense
  • Sponsor:Asac Pharmaceutical Inmunology S.A.

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Cuenca

What the registry says about research in the country

01 Allergy and Immunology

Innovative research focusing on polymerized allergen extracts for treating seasonal allergies affecting respiratory health.

  • Allergic Rhinitis/Rhinoconjunctivitis
  • Grass and Cupressaceae Allergies
  • Controlled Asthma Management

This trial aims to improve treatment options for patients with moderate to severe allergic conditions during peak pollen seasons.

02 Oncology

Comprehensive research tracking the progression of early-stage breast cancer through long-term patient monitoring.

  • Invasive Breast Cancer
  • Disease Relapse Patterns
  • Treatment Outcomes

The study follows patients from previous GEICAM trials to understand disease progression and treatment effectiveness.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.